+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cardiac Abnormalities in Alzheimer Disease: Clinical Relevance Beyond Pathophysiological Rationale and Instrumental Findings?



Cardiac Abnormalities in Alzheimer Disease: Clinical Relevance Beyond Pathophysiological Rationale and Instrumental Findings?



Jacc. Heart Failure 7(2): 121-128



This case control study sought to assess the presence and characteristics of cardiac abnormalities in patients with Alzheimer disease (AD). Protein misfolding is involved in the pathophysiology of neurodegenerative disorders such as AD. Recently, amyloid-beta (Aβ) aggregates were identified within the cardiomyocytes and interstitium of patients with AD, suggesting that Aβ oligomers may reach and damage the heart. The authors studied 32 patients with AD and 34 controls matched by age and sex, all of whom were free from cardiac or systemic diseases. A clinical evaluation, an electrocardiogram, and an echocardiogram were performed in all subjects. Furthermore, patients with AD underwent genetic analyses (of the PSEN1, PSEN2, APP, and APOE genes). Compared to the control group, patients with AD had a higher prevalence of low-voltage electrocardiographic QRS complexes (28% vs. 3%, respectively; p = 0.004), a lower voltage/mass ratio (p = 0.05), a greater echocardiographic interventricular septum (10.1 ± 1.3 mm vs. 9.3 ± 1.1 mm, respectively; p = 0.01), a greater maximum wall thickness (10.8 ± 1.7 mm vs. 9.3 ± 1.1 mm, respectively; p = 0.0001), and a 2-fold higher prevalence of diastolic dysfunction (70% vs. 35%, respectively; p = 0.007). Symptoms and signs of heart failure were absent in all patients with AD. This study shows that electrocardiographic and echocardiographic abnormalities, including diastolic dysfunction, are present in patients with AD and that these studies reproduce the pattern of cardiac amyloidosis. These findings suggest that, in AD, there may be subclinical cardiac involvement likely associated with Aβ amyloid deposition. The clinical relevance of these cardiac abnormalities should be evaluated in larger prospective studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446691

Download citation: RISBibTeXText

PMID: 30704603

DOI: 10.1016/j.jchf.2018.10.022


Related references

Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?. Clinical Chemistry and Laboratory Medicine 40(8): 752-760, 2002

Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate. Clinical Neuropharmacology 11(1): 18-35, 1988

The cholinergic pathology in Alzheimer's disease - discrepancies between clinical experience and pathophysiological findings. Journal of Neural Transmission 109(7-8): 1003-1014, July, 2002

Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: pathophysiological relevance for Alzheimer's disease?. Brain Research 1542: 32-40, 2014

Abnormalities of cardiac conduction in sinus node disease. Correlation with clinical findings. Cor et Vasa 19(3): 197-206, 1977

Clinical and instrumental findings in cardiac amyloidosis. Giornale Italiano di Cardiologia 23(1): 73-77, 1993

Tako-tsubo-like left ventricular dysfunction: clinical presentation, instrumental findings, additional cardiac and non-cardiac diseases and potential pathomechanisms. Minerva Cardioangiologica 53(2): 139-145, 2005

Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders 10(3): 132-140, 1996

Gastro-oesophageal reflux disease: Pathophysiological issues of clinical relevance. Alimentary Pharmacology & Therapeutics 16(Supplement 4): 65-71, July, 2002

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflammatory Bowel Diseases 13(8): 1016-1023, 2007

Cardiac abnormalities in myotonic dystrophy. Electrocardiographic and echocardiographic findings in 65 patients and 34 of their unaffected relatives. Relation with age and sex and relevance for gene detection. Journal of the Neurological Sciences 80(2-3): 259-268, 1987

Review article: gastro-oesophageal reflux disease--pathophysiological issues of clinical relevance. Alimentary Pharmacology and Therapeutics 16 Suppl 4: 65-71, 2002

Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease. Cell Cycle 13(6): 898-909, 2014

COMT inhibition in Parkinson's disease: rationale and clinical relevance. Acta Neurologica Belgica 100(1): 5-7, 2000

Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimer's & Dementia 7(4): S373-S374, 2011